Literature DB >> 10874299

Private beta- and gamma-sarcoglycan gene mutations: evidence of a founder effect in Northern Italy.

M Fanin1, E P Hoffman, C Angelini, E Pegoraro.   

Abstract

Autosomal recessive muscular dystrophies called "sarcoglycanopathies" result from mutations in the genes encoding alpha-, beta-, gamma-, or delta-sarcoglycan complex components. The present study involved six unrelated families from Northern Italy showing mutations in the beta- or gamma-sarcoglycan genes. An 8 bp duplication in the beta-sarcoglycan gene and 1 bp insertion in the gamma-sarcoglycan gene occur with high frequency in our population. These mutations have never been reported thus far in other countries. Many patients are homozygotes for a single mutation, although they derived from non-consanguineous marriages. We suggest that these alleles are "private" mutations of this geographical region. A panel of highly informative microsatellite markers that map in the beta- and gamma-sarcoglycan gene locus was used to assess the haplotypes among affected patients and control population, in order to test the presence of linkage disequilibrium. We found that the 8 bp duplication in the beta-sarcoglycan gene and the 1 bp insertion in the gamma-sarcoglycan gene are in linkage disequilibrium with neighbouring polymorphisms. The recurrence of specific sarcoglycan mutations in Northern Italy is probably due to a founder effect, combined with a relative genetic isolation. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874299     DOI: 10.1002/1098-1004(200007)16:1<13::AID-HUMU3>3.0.CO;2-V

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  Exploring the underlying biology of intrinsic cardiorespiratory fitness through integrative analysis of genomic variants and muscle gene expression profiling.

Authors:  Sujoy Ghosh; Monalisa Hota; Xiaoran Chai; Jencee Kiranya; Palash Ghosh; Zihong He; Jonathan J Ruiz-Ramie; Mark A Sarzynski; Claude Bouchard
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

2.  Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E.

Authors:  Claudio Semplicini; John Vissing; Julia R Dahlqvist; Tanya Stojkovic; Luca Bello; Nanna Witting; Morten Duno; France Leturcq; Cinzia Bertolin; Paola D'Ambrosio; Bruno Eymard; Corrado Angelini; Luisa Politano; Pascal Laforêt; Elena Pegoraro
Journal:  Neurology       Date:  2015-04-10       Impact factor: 9.910

Review 3.  Limb-girdle Muscular Dystrophies in India: A Review.

Authors:  Satish V Khadilkar; Hinaben Dayalal Faldu; Sarika Bapuso Patil; Rakesh Singh
Journal:  Ann Indian Acad Neurol       Date:  2017 Apr-Jun       Impact factor: 1.383

4.  LGMD. Identification, description and classification.

Authors:  Corrado Angelini
Journal:  Acta Myol       Date:  2020-12-01

5.  Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the SGCB Gene.

Authors:  Francesca Magri; Simona Zanotti; Sabrina Salani; Francesco Fortunato; Patrizia Ciscato; Simonetta Gerevini; Lorenzo Maggi; Monica Sciacco; Maurizio Moggio; Stefania Corti; Nereo Bresolin; Giacomo Pietro Comi; Dario Ronchi
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

6.  Epidemiology of muscular dystrophies in the Mediterranean area.

Authors:  Haluk Topaloglu
Journal:  Acta Myol       Date:  2013-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.